BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3067484)

  • 21. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
    Stigum H; Magnus P; Samdal HH; Nord E
    Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic challenges: lymphotropic sero-"questionables".
    Fox E; Constantine NT; Rodier G; Abbatte EA
    East Afr Med J; 1992 Oct; 69(10):563-5. PubMed ID: 1473510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-associated transmission of human T-lymphotropic virus types I and II: experience of a regional blood center.
    Herr V; Ambruso D; Fairfax M; Neumann A; Swanson P; Lee H
    Transfusion; 1993 Mar; 33(3):208-11. PubMed ID: 8438220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010.
    Hakre S; Manak MM; Murray CK; Davis KW; Bose M; Harding AJ; Maas PR; Jagodzinski LL; Kim JH; Michael NL; Rentas FJ; Peel SA; Scott PT; Tovanabutra S
    Transfusion; 2013 Oct; 53(10):2176-82. PubMed ID: 23362944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Residual risk of retrovirus transmission by transfusions].
    Soriano V; Heredia A
    Rev Clin Esp; 1995 Jun; 195(6):418-24. PubMed ID: 7644794
    [No Abstract]   [Full Text] [Related]  

  • 26. Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
    Sobata R; Matsumoto C; Uchida S; Suzuki Y; Satake M; Tadokoro K
    Vox Sang; 2015 Aug; 109(2):122-8. PubMed ID: 25930000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
    Broutet N; de Queiroz Sousa A; Basilio FP; Sá HL; Simon F; Dabis F
    Int J STD AIDS; 1996; 7(5):365-9. PubMed ID: 8894828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human immunodeficiency virus and other viruses in human milk: placing the issues in broader perspective.
    Oxtoby MJ
    Pediatr Infect Dis J; 1988 Dec; 7(12):825-35. PubMed ID: 2850525
    [No Abstract]   [Full Text] [Related]  

  • 30. An update on transfusion-transmitted viruses.
    Luban NL
    Curr Opin Pediatr; 1998 Feb; 10(1):53-9. PubMed ID: 9529639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion].
    Lefrère JJ
    Presse Med; 2000 Jun; 29(20):1134-8. PubMed ID: 10901796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The problem of transfusion-associated acquired immunodeficiency syndrome in Africa: a quantitative approach.
    Heymann SJ; Brewer TF
    Am J Infect Control; 1992 Oct; 20(5):256-62. PubMed ID: 1443758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic transfusion risks in the surgical patient.
    Klein HG
    Am J Surg; 1995 Dec; 170(6A Suppl):21S-26S. PubMed ID: 8546242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
    Opaleye OO; Igboama MC; Ojo JA; Odewale G
    J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual transmission of human T-lymphotropic virus type I (HTLV-I).
    Murphy EL; Figueroa JP; Gibbs WN; Brathwaite A; Holding-Cobham M; Waters D; Cranston B; Hanchard B; Blattner WA
    Ann Intern Med; 1989 Oct; 111(7):555-60. PubMed ID: 2789009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of human T-lymphotrophic virus type I infection to a neonatal infant by transfusion of washed and irradiated red cells.
    DePalma L; Luban NL
    Transfusion; 1993 Jul; 33(7):582-4. PubMed ID: 8333021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serodiagnosis of infection with the AIDS virus and other human retroviruses.
    Schochetman G; Epstein JS; Zuck TF
    Annu Rev Microbiol; 1989; 43():629-59. PubMed ID: 2679365
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.